A. FERGUSON: Open Payments
NPI 1750390902 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,534 in 213 payments from 23 companies in 2025. Trend: 2023 $4,154 · 2024 $3,950 · 2025 $4,534
Food & beverage: $4,462Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $1,015 |
| Janssen Biotech, Inc. | 18 | $425 |
| LEO Pharma Inc. | 19 | $420 |
| UCB, Inc. | 18 | $380 |
| Galderma Laboratories, L.P. | 20 | $332 |
| Regeneron Healthcare Solutions, Inc. | 6 | $255 |
| GENZYME CORPORATION | 9 | $244 |
| Novartis Pharmaceuticals Corporation | 15 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $213 |
| Incyte Corporation | 6 | $173 |
Products named: TREMFYA, DUPIXENT, Bimzelx, ADBRY, SKYRIZI, RINVOQ, BOTOX, NEMLUVIO.
Industry payments across IN — which companies pay providers there.
